OPT Congress 2026 is the leading industry event for scientists, directors, and technology providers driving innovation across oligonucleotide, mRNA, and peptide therapeutics. This year’s agenda brings together experts from discovery through development, with dedicated content spanning AI-enabled design, extrahepatic delivery, scalable manufacturing, and next-gen modalities including saRNA, circular RNA, and radioligand peptide conjugates.

Meet our colleagues at OPT in Boston from March 18 to 19 to discuss your oligo projects with us.